Development of small molecule senolytics for the modulation of senescence in neurodegenerative diseases. (#525)
Jessica O'Driscoll
1
,
Alexandra Maximova
1
,
Nathan Castellino
1
,
Andrew Montgomery
1
,
Eryn Werry
1
2
,
Michael Kassiou
1
- School of Chemistry , University of Sydney, Sydney, NSW, Australia
- Central Clinical School, University of Sydney, Sydney, NSW, Australia
Publish consent withheld
- Tao et al. Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity. ACS Med. Chem. Lett. 2014, 5 (10), 1088–1093.